Study to Evaluate a Single Intranasal Dose of STI-2099 (COVI-DROPS™) in Outpatient Adults With COVID-19 (UK)
Status:
Recruiting
Trial end date:
2022-03-01
Target enrollment:
Participant gender:
Summary
This is a double-blind study designed to investigate the efficacy, safety and PK of a single
dose of COVI-DROPS or matched placebo in outpatient adults who have tested positive for
COVID-19 and are either asymptomatic or have mild symptoms.